Gracell Biotechnologies Inc. ( Show more
Location: | Website: www.gracellbio.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$10.25
Open
$10.25
Volume
N/A
Day Range
$10.25 - $10.25
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
16.39%
Institutional Own.
63.11%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GC012F Details Multiple myeloma, Cancer | Phase 1/2 Data readout | |
GC012F Details Autoimmune disease, Systemic lupus erythematosus | Phase 1/2 Initiation | |
GC007g Details B-cell acute lymphoblastic leukemia | Failed Discontinued |